Urticaria: WAO Online Lectures
DESCRIPTIONUrticaria is one of the most common atopic diseases worldwide, and its increasing incidence globally is associated with a reduced quality of life. This self-directed, electronic learning series features expert lecturers on urticaria who provide an overview from diagnosis to management: (a) Definition, classification, and etiology; (2) Clinical features, diagnosis, and pathogenic mechanisms of urticaria and angioedema; (3) Chronic spontaneous urticaria; and (4) Management of urticaria.
TARGET AUDIENCE
This learning program will be valuable to allergists/immunologists and any clinicians interested in the diagnosis and management of urticaria. This series will be especially valuable for physicians in the emerging markets that the World Allergy Organization serves through its Emerging Societies Program.
FACULTY
Mario Sánchez-Borges, MD, PhD, is Associate Professor of the Department of Allergy and Clinical Immunology with Centro Medico-Docente La Trinidad, in Caracas, Venezuela.
Conflict of Interest Declaration: Mario Sánchez-Borges, MD, PhD, declares he is a speaker for FAES Farma (Spain) and a member of the advisory boards of Novartis and Genentech.
Allen P. Kaplan, MD, is Clinical Professor of Medicine at the Medical University of South Carolina in Charleston, South Carolina, and Staff Physician at the National Allergy, Asthma, and Urticaria Centers of Charleston, South Carolina, United States of America.Conflict of Interest Declaration: Allen P. Kaplan, MD, declares he is a consultant for Novartis and Genentech.
Michihiro Hide, MD, PhD, is Professor and Chairman of the Department of Dermatology at Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.Conflict of Interest Declaration: Michihiro Hide, MD, PhD, declares his receives research support from: GlaxoSmithKline, Japan Boehringer Ingelheim, Tanabe-Mitsubishi, Shionogi, Sanofi, Kyouwahakkou-Kirin, Novartis Pharma, and Shimense Healthcare. He receives consultancy fees from GlaxoSmithKline, Sanofi, and MSD.
Jonathan Bernstein, MD, is Professor of Medicine in the Department of Internal Medicine, Division of Allergy and Immunology, at University of Cincinnati, Cincinnati, Ohio, United States of America.Conflict of Interest Declaration: Jonathan Bernstein, MD, declares he is a principal investigator for Novartis and Genentech.
PLANNING COMMITTEE
Ruby Pawankar, MD, PhD, is Professor of Allergy in the Department of Pediatrics at Nippon Medical School in Tokyo, Japan, and Guest Professor at the Kyung Hee University School of Medicine in Seoul, Korea and Showa University School of Medicine in Tokyo, Japan.
Conflict of Interest Declaration: Ruby Pawankar, MD, PhD, declares she has no competing interests related to this project.
Suwat Benjaponpitak, MD, is Associate Professor of Pediatrics; Head, Division of Pediatric Allergy, Immunology, and Rheumatology; Associate Dean for Education, Faculty of Medicine, with Ramathibodi Hospital, Mahidol University, Thailand.
Conflict of Interest Declaration: Suwat Benjaponpitak, MD, declares he has no competing interests related to this project.
WAO Contact Information
World Allergy Organization
555 East Wells Street, Suite 1100
Milwaukee, Wisconsin 53202-3823 USA
Phone: +1-414-276-1791 Fax: +1-414-276-3349
E-mail: info@worldallergy.org Internet: www.WorldAllergy.org